{{Rsnum
|rsid=16951120
|Chromosome=17
|position=52216278
|Orientation=plus
|GMAF=0.1129
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 83.1 | 15.4 | 1.5
| HCB | 80.0 | 20.0 | 0.0
| JPT | 91.1 | 8.9 | 0.0
| YRI | 66.1 | 32.3 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 80.0 | 20.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=6E-6
  |OR=4.49
  |ORtxt=[2.55-6.43] mg/dL increase
  |OA=1
}}

{{on chip | FTDNA}}